TotalMarketCap

GT Biopharma

GTBPNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$9.445 M

$4.58 -5.32%

Close of 6 Nov 2026

As of 6 Nov 2026, GT Biopharma (GTBP) has a market capitalization of $9.44M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$28.4M

Loss-making

Shares outstanding

45,109,497

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #416Rocket OneRKTO$10.0M
  2. #417Aspire-LakewoodASBP$9.58M
  3. #418GT BiopharmaGTBP$9.44M
  4. #419Phio PharmaceuticalsPHIO$9.29M
  5. #420Moleculin BiotechMBRX$9.16M

What if GT Biopharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$13,700,224

Per share 2,989,683× higher

Bitcoin $1.53T

$741,295.24

Per share 161,767× higher

Apple $5.02T

$2,433,603

Per share 531,065× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for GT Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.